Showing results (311-320 of 392) with videos related to

Sort By:
Pageof 40
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2015
Codelivery of Envelope Protein in Alum with MVA Vaccine Induces CXCR3-Biased CXCR5+ and CXCR5- CD4 T Cell Responses in Rhesus MacaquesSmita S Iyer, Sailaja Gangadhara, Blandine Victor, et al.
Vaccine|May 27, 2004
Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathologyLeon de Waal, Linda S Wyatt, Selma Yüksel, et al.
AIDS Research and Human Retroviruses|December 28, 2007
Immunogenicity in macaques of the clinical product for a clade B DNA/MVA HIV vaccine: elicitation of IFN-gamma, IL-2, and TNF-alpha coproducing CD4 and CD8 T cellsHarriet L Robinson, Sunita Sharma, Jun Zhao, et al.
Nature Communications|May 21, 2025
Mpox multiprotein virus-like nanoparticle vaccine induces neutralizing and protective antibodies in mice and non-human primatesAhmed A Belghith, Catherine A Cotter, Maxinne A Ignacio, et al.
Vaccine|May 20, 2009
Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunityLindvi Gudmundsdotter, Charlotta Nilsson, Andreas Brave, et al.
Vaccines|December 20, 2017
Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope ProteinsSailaja Gangadhara, Young-Man Kwon, Subbiah Jeeva, et al.
Virology|June 3, 2006
Studies on GM-CSF DNA as an adjuvant for neutralizing Ab elicited by a DNA/MVA immunodeficiency virus vaccineHarriet L Robinson, David C Montefiori, Francois Villinger, et al.
The American Journal of Medicine|November 26, 2008
Immunity from smallpox vaccine persists for decades: a longitudinal studyDennis D Taub, William B Ershler, Mark Janowski, et al.
Plos Pathogens|October 10, 2022
Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entryLalita Priyamvada, Wouter W Kallemeijn, Monica Faronato, et al.
Vaccine|March 8, 2011
Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaquesMarta L Marthas, Koen K A Van Rompay, Zachary Abbott, et al.
Pageof 40